+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study



Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study



Contraception 69(5): 407-412



This 1-year randomized study was carried out at family-planning clinics of two university hospitals to compare the safety and acceptability of a levonorgestrel-releasing intrauterine system (LNG IUS) and oral contraceptives (OCs) in young nulliparous women. The study population consisted of 200 women aged 18-25 years seeking contraception. Ninety-four women entered the LNG IUS group and 99 entered the OC group. Continuation rates, reasons leading to discontinuation, adverse events, menstrual questionnaires, subjective well-being and sexual behavior were evaluated. Nineteen women (20%) in the LNG IUS group discontinued the study during the 1-year observation period, and 27 discontinued (27%) in the OC group. The most common reason (31%) for discontinuation in the IUS group was pain. In the OC group, hormonal side effects were the predominant medical reason for study termination. The safety and acceptability of the LNG IUS for contraception was observed to be as good as with OCs, with a high continuation rate.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011865672

Download citation: RISBibTeXText

PMID: 15105064

DOI: 10.1016/j.contraception.2003.11.008


Related references

Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study. Zhonghua Yi Xue Za Zhi 91(15): 1047-1050, 2011

In women over 35 years of age who smoke, does mirena (levonorgestrel-releasing intrauterine system) reduce the risk of DVTs compared to oral contraceptives?. Journal of the Oklahoma State Medical Association 106(9): 362-363, 2014

Use of the levonorgestrel releasing-intrauterine system in nulliparous women--a non-interventional study in Sweden. European Journal of Contraception and Reproductive Health Care 16(2): 126-134, 2011

Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence. Acta Obstetricia et Gynecologica Scandinavica 93(1): 38-44, 2014

Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population. American Journal of Obstetrics and Gynecology 199(5): 529.E1-529.E10, 2008

Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. Contraception 95(4): 405-413, 2017

Pain Perception during Levonorgestrel-releasing Intrauterine Device Insertion in Nulliparous Women: A Systematic Review. Journal of Pediatric and Adolescent Gynecology 31(6): 549-556.E4, 2018

Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study. Fertility and Sterility 39(2): 187-192, 1983

The levonorgestrel intrauterine system in nulliparous women. Contraception 75(6 Suppl): S12-S15, 2007

Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women. International Journal of Gynecological Cancer 27(6): 1178-1182, 2017

General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK. European Journal of Contraception and Reproductive Health Care 16(4): 311-318, 2011

A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion. Contraception 69(3): 247-250, 2004

Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report. Journal of Minimally Invasive Gynecology 16(5): 630-633, 2009

Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception 84(5): E11-E16, 2011

A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Yearbook of Obstetrics Gynecology and Women's Health 2007: 211-212, 2007